Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems

Whereas the cellular and molecular features of human inflammatory skin diseases are well characterized, their tissue context and systemic impact remain poorly understood. We thus profiled human psoriasis (PsO) as a prototypic immune-mediated condition with a high predilection for extracutaneous involvement. Spatial transcriptomics (ST) analyses of 25 healthy, active lesion, and clinically uninvolved skin biopsies and integration with public single-cell transcriptomics data revealed marked differences in immune microniches between healthy and inflamed skin. Tissue-scale cartography further identified core disease features across all active lesions, including the emergence of an inflamed suprabasal epidermal state and the presence of B lymphocytes in lesional skin. Both lesional and distal nonlesional samples were stratified by skin disease severity and not by the presence of systemic disease. This segregation was driven by macrophage-, fibroblast-, and lymphatic-enriched spatial regions with gene signatures associated with metabolic dysfunction. Together, these findings suggest that mild and severe forms of PsO have distinct molecular features and that severe PsO may profoundly alter the cellular and metabolic composition of distal unaffected skin sites. In addition, our study provides a valuable resource for the research community to study spatial gene organization of healthy and inflamed human skin. Description Spatial transcriptomics provides insight into the cellular, immune, and molecular landscape of psoriatic disease pathogenesis. Editor’s summary Psoriasis is a chronic inflammatory skin disease that is often accompanied by systemic complications. Using spatial transcriptomics (ST), Castillo and Sidhu et al. examined the composition of immune niches within skin biopsies obtained from psoriasis patients with or without arthritis and healthy individuals. By integrating ST with publicly available single cell transcriptomics data to achieve cellular resolution, they found that psoriasis was associated with repositioning of immune cells, including B cells, into the upper layers of the skin. Pathological features detected in psoriasis were present in both lesional and nonlesional skin, demonstrating the broad effects of psoriatic inflammation even distal to clinically affected skin. ST could also stratify samples on the basis of clinical disease severity, highlighting the profound changes in the spatial organization of the skin during the progression of psoriasis. —Claire Olingy

[1]  E. Fuchs,et al.  Inflammatory memory and tissue adaptation in sickness and in health , 2022, Nature.

[2]  A. Heguy,et al.  Interleukin-17 governs hypoxic adaptation of injured epithelium , 2022, Science.

[3]  Charles H. Yoon,et al.  An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes. , 2022, Cancer cell.

[4]  M. Pellegrini,et al.  Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation , 2022, Science Translational Medicine.

[5]  C. Danko,et al.  Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology , 2022, Nature Cancer.

[6]  H. Pasolli,et al.  A lymphatic-stem cell interactome regulates intestinal stem cell activity , 2022, bioRxiv.

[7]  S. Naik,et al.  Immune-Epithelial Cross Talk in Regeneration and Repair , 2022, Annual review of immunology.

[8]  S. Naik One Size Does Not Fit All: Diversifying Immune Function in the Skin , 2022, The Journal of Immunology.

[9]  Y. Helfrich,et al.  Cytokine responses in non-lesional psoriatic skin as clinical predictor to anti-TNF agents. , 2021, The Journal of allergy and clinical immunology.

[10]  G. Kollias,et al.  Fibroblasts as immune regulators in infection, inflammation and cancer , 2021, Nature Reviews Immunology.

[11]  M. Pellegrini,et al.  Single cell sequencing of human white adipose tissue identifies novel cell states in health and obesity , 2021, Nature Immunology.

[12]  T. Matsushita,et al.  Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells , 2021, Scientific Reports.

[13]  S. Teichmann,et al.  Developmental cell programs are co-opted in inflammatory skin disease , 2021, Science.

[14]  S. Arron,et al.  Single cell RNA-seq of psoriatic skin identifies pathogenic Tc17 subsets and reveals distinctions between CD8+ T cells in autoimmunity and cancer. , 2020, The Journal of allergy and clinical immunology.

[15]  J. Wenzel,et al.  Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases—Implications for Therapeutic Approaches , 2020, Cells.

[16]  J. C. Love,et al.  Second-Strand Synthesis-Based Massively Parallel scRNA-Seq Reveals Cellular States and Molecular Features of Human Inflammatory Skin Pathologies , 2020, Immunity.

[17]  G. Ogg,et al.  Role of regulatory T cells in psoriasis pathogenesis and treatment , 2020, The British journal of dermatology.

[18]  Itai Yanai,et al.  Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas , 2020, Nature Biotechnology.

[19]  Y. Saeys,et al.  NicheNet: modeling intercellular communication by linking ligands to target genes , 2019, Nature Methods.

[20]  Ronald R. Coifman,et al.  Visualizing structure and transitions in high-dimensional biological data , 2019, Nature Biotechnology.

[21]  H. Chou,et al.  FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR , 2019, BMC Cancer.

[22]  L. Skov,et al.  Localization of treatment‐resistant areas in patients with psoriasis on biologics , 2019, The British journal of dermatology.

[23]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[24]  Tetsuro Kobayashi,et al.  Choreographing Immunity in the Skin Epithelial Barrier , 2019, Immunity.

[25]  A. Ogdie,et al.  Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition , 2019, Nature Reviews Rheumatology.

[26]  M. Swartz,et al.  Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis. , 2019, Cell metabolism.

[27]  F. Ginhoux,et al.  The immunological anatomy of the skin , 2018, Nature reviews. Immunology.

[28]  Fan Zhang,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.

[29]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[30]  J. Gudjonsson,et al.  IL‐1 and IL‐36 are dominant cytokines in generalized pustular psoriasis , 2017, The Journal of allergy and clinical immunology.

[31]  J. Merola,et al.  The psychosocial burden of psoriatic arthritis. , 2017, Seminars in arthritis and rheumatism.

[32]  A. Butte,et al.  xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, bioRxiv.

[33]  L. Coates,et al.  Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same? , 2016, Seminars in arthritis and rheumatism.

[34]  M. Suárez-Fariñas,et al.  The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes. , 2016, The Journal of investigative dermatology.

[35]  James T. Elder,et al.  Sebaceous Gland Atrophy in Psoriasis: An Explanation for Psoriatic Alopecia? , 2016, The Journal of investigative dermatology.

[36]  John C Marioni,et al.  A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor , 2016, F1000Research.

[37]  J. Lu,et al.  CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity , 2016, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[38]  Patrik L. Ståhl,et al.  Visualization and analysis of gene expression in tissue sections by spatial transcriptomics , 2016, Science.

[39]  D. Gladman,et al.  The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study , 2016, Arthritis & rheumatology.

[40]  H. Nakagawa,et al.  IL-10-producing regulatory B cells are decreased in patients with psoriasis. , 2016, Journal of dermatological science.

[41]  P. Farrant,et al.  Psoriatic alopecia , 2015, Clinical and experimental dermatology.

[42]  Z. Zhai,et al.  Increased circulating follicular helper T cells and activated B cells correlate with disease severity in patients with psoriasis , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[43]  Christoph Wilhelm,et al.  Commensal–dendritic-cell interaction specifies a unique protective skin immune signature , 2015, Nature.

[44]  Andrew Johnston,et al.  Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms , 2014, The Journal of investigative dermatology.

[45]  C. Deming,et al.  Compartmentalized Control of Skin Immunity by Resident Commensals , 2012, Science.

[46]  O. FitzGerald,et al.  High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires , 2012, Annals of the rheumatic diseases.

[47]  Jun Yan,et al.  New insights of T cells in the pathogenesis of psoriasis , 2012, Cellular and Molecular Immunology.

[48]  Gang Wang,et al.  IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms. , 2011, The Journal of investigative dermatology.

[49]  D. Gladman,et al.  Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis , 2011, Arthritis care & research.

[50]  A. Qureshi,et al.  Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. , 2011, Archives of dermatology.

[51]  M. Landthaler,et al.  FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes. , 2010, Experimental cell research.

[52]  H. Tey,et al.  Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis , 2010, The Journal of dermatology.

[53]  Anna-Katharina Müller,et al.  Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis , 2010, The Journal of cell biology.

[54]  G. Sadeghian,et al.  Evaluation of insulin resistance in obese women with and without acanthosis nigricans , 2009, The Journal of dermatology.

[55]  S. Gabriel,et al.  Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. , 2009, Arthritis and rheumatism.

[56]  E. Spector,et al.  Familial acanthosis nigricans due to K650T FGFR3 mutation. , 2007, Archives of dermatology.

[57]  R. Schwartz,et al.  Juvenile acanthosis nigricans. , 2007, Journal of the American Academy of Dermatology.

[58]  M. Landthaler,et al.  FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization , 2007, Modern Pathology.

[59]  F. Real,et al.  Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors. , 2007, The Journal of investigative dermatology.

[60]  Daniel B. Shin,et al.  Prevalence of cardiovascular risk factors in patients with psoriasis. , 2022, Central European journal of public health.

[61]  Daniel B. Shin,et al.  Risk of myocardial infarction in patients with psoriasis. , 2006, JAMA.

[62]  R. Stern,et al.  Epidemiology of psoriatic arthritis in the population of the United States. , 2005, Journal of the American Academy of Dermatology.

[63]  A. Jovelić,et al.  Psoriatic arthritis: a retrospective study of 162 patients. , 2005, Vojnosanitetski pregled.

[64]  M. Knowles,et al.  Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. , 2005, Experimental cell research.

[65]  Robert V Farese,et al.  Lipopenia and Skin Barrier Abnormalities in DGAT2-deficient Mice* , 2004, Journal of Biological Chemistry.

[66]  S. Feldman A quantitative definition of severe psoriasis for use in clinical trials , 2004, The Journal of dermatological treatment.

[67]  F. Mahmoud,et al.  Elevated B‐Lymphocyte Levels in Lesional Tissue of Non‐Arthritic Psoriasis , 1999, The Journal of dermatology.

[68]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[69]  T. Hamilton,et al.  A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia. , 1989, Archives of dermatology.

[70]  A. Paller,et al.  An IL‐17–dominant immune profile is shared across the major orphan forms of ichthyosis , 2017, The Journal of allergy and clinical immunology.

[71]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[72]  O. Larko Problem sites: scalp, palm and sole, and nail. , 1995, Dermatologic clinics.